4.6 Tissue Injury and Aging Study Notes

Tissue Injury and Aging

Learning Outcomes

  • By the end of this section, students will be able to:

    • Identify the cardinal signs of inflammation.

    • List the body’s response to tissue injury.

    • Explain the process of tissue repair.

    • Discuss the progressive impact of aging on tissue.

    • Describe cancerous mutations’ effect on tissue.

Introduction

  • Tissues of all types are vulnerable to injury and aging.

  • Understanding how tissues respond to damage can guide strategies to aid repair.

  • Recognizing the impact of aging can assist in diminishing its adverse effects.

Tissue Injury and Repair

Inflammation

  • Inflammation is the standard, initial response of the body to injury.

    • Types of injury include biological, chemical, physical, and radiation burns.

    • All injuries lead to a similar sequence of physiological events.

  • Functions of inflammation:

    • Limits the extent of injury.

    • Partially or fully eliminates the cause of injury.

    • Initiates repair and regeneration of damaged tissue.

  • Necrosis (accidental cell death) causes inflammation.

  • Apoptosis (programmed cell death) is a normal, step-by-step process that destroys cells that are no longer needed.

    • Apoptosis does not initiate the inflammatory response.

  • Chronic inflammation occurs if acute inflammation persists, leading to diseased conditions.

    • Examples include arthritis and tuberculosis.

Cardinal Signs of Inflammation

  • Four cardinal signs of inflammation (first documented by Cornelius Celsus in the first century AD):

    • Redness

    • Swelling

    • Pain

    • Local heat

    • A fifth sign, loss of function, may also accompany inflammation.

Mechanism of Inflammation

  • Upon tissue injury, damaged cells release inflammatory chemical signals leading to:

    • Local vasodilation (widening of blood vessels).

    • Increased blood flow results in apparent redness and heat.

  • Mast cells present in tissue degranulate to release histamine (a potent vasodilator):

    • Increased blood flow and inflammatory mediators recruit white blood cells to the site of inflammation.

  • The endothelium lining local blood vessels becomes “leaky,” allowing neutrophils, macrophages, and fluid to move into the interstitial tissue spaces.

    • Excess liquid causes swelling, known as edema.

    • Swollen tissues squeeze pain receptors leading to the sensation of pain.

  • Prostaglandins released from injured cells activate pain neurons.

  • Non-steroidal anti-inflammatory drugs (NSAIDs) reduce pain by inhibiting prostaglandin synthesis.

    • High levels of NSAIDs also reduce inflammation.

  • Antihistamines decrease allergies by blocking histamine receptors and the resultant histamine response.

Tissue Repair Process

  • After containing an injury, the tissue repair phase begins:

    • Removal of toxins and waste products occurs.

    • Clotting (coagulation) reduces blood loss from damaged blood vessels:

    • Forms a network of fibrin proteins that trap blood cells and bind the edges of the wound together.

    • A scab forms when the clot dries, reducing the risk of infection.

  • At times, a mixture of dead leukocytes and fluid, termed pus, accumulates in the wound.

  • Healing progress involves fibroblasts from surrounding connective tissues replacing lost collagen and extracellular material.

  • Angiogenesis (growth of new blood vessels) results in vascularization of new tissue known as granulation tissue.

    • The clot retracts, pulling the edges of the wound together.

    • It slowly dissolves as the tissue is repaired.

  • When a large amount of granulation tissue forms, and capillaries disappear, a pale scar often becomes visible in the healed area.

  • Primary union describes healing of a wound where edges are close together.

    • In a gaping wound, the healing takes longer (referred to as secondary union) as edges are pulled together via wound contraction.

    • For wounds deeper than a quarter inch, sutures (stitches) are recommended to promote primary union and avoid disfiguring scars.

  • Regeneration is the addition of new cells of the same type as those injured.

Tissue and Aging

Impact of Aging on Tissues

  • Aging leads to a decline in bodily functions, confirmed biologically.

    • All cells, tissues, and organs are affected by senescence with noticeable variability among individuals due to genetics and lifestyle.

  • Outward signs of aging:

    • Skin and other tissues become thinner and drier, reducing elasticity

    • Contributes to wrinkles and hypertension.

    • Hair turns gray due to reduced melanin production in hair follicles.

    • Facial appearance becomes flabby due to decreased elasticity and collagen fibers in connective tissue.

    • Joints lose cartilage and become stiff;

    • The height decreases as bones lose calcium and other minerals.

  • Internal signs of aging may not be as noticeable:

    • Increased incidences of heart disease, respiratory syndromes, and type 2 diabetes do not correlate strictly with age.

  • Wound healing slows in the elderly, with a higher frequency of infections due to declining immune system capacity.

Cellular Aging

  • Aging is evident at cellular levels:

    • Telomeres, segments of chromosomes necessary for cell division, shorten with each cell division, limiting renewable capabilities.

    • Alterations in cell membranes reduce the efficiency of nutrients and oxygen transport into the cell and waste product removal.

    • Such changes can lead to abnormal cell function and diseases like arthritis and some cancers.

  • Individual variability in the impact of aging exists:

    • Studies indicate that exercise and a healthy lifestyle can slow down bodily deterioration associated with aging.

Tissues and Cancer

Understanding Cancer

  • Cancer is a generic term for diseases where cells avoid regulatory signals leading to:

    • Uncontrolled growth.

    • Invasion into adjacent tissues.

    • Colonization of other organs if untreated.

    • Tumors compete for blood supply, impacting the health of normal organs.

  • A mutation is a permanent change in the DNA of a cell.

    • Epigenetic modifications are changes that do not affect the DNA code but alter its decoding mechanisms, potentially resulting in abnormal cells.

  • Genetic material alterations may result from environmental agents, infectious agents, or errors during DNA replication that accumulate over time.

  • Many mutations do not visibly change cell functions; however, mutations impacting key proteins that regulate orderly cell proliferation can lead to abnormal divisions:

    • Tissues lose their organizational abilities as mutations accumulate, forming tumors.

  • A tumor is a mass of cells with abnormal architecture:

    • Many tumors are benign, characterized by non-metastastic behavior.

    • Tumors become malignant (cancerous) when they breach tissue boundaries, promote angiogenesis, and metastasize to other organs.

Types of Cancer

  • Cancers derived from epithelial cells are called carcinomas.

  • Myeloid tissue or blood cell cancers are termed myelomas.

  • Leukemias refer to cancers of white blood cells.

  • Sarcomas arise from connective tissue.

Tumor Characteristics

  • Tumor cells differ in structure and function:

    • Some are identified as cancer stem cells, which may be responsible for uncontrolled growth.

    • Modern research shows that tumors possess structured organization rather than appearing as disorganized masses of cells.

Cancer Treatments

  • Cancer treatment strategies vary based on type and stage:

    • Traditional methods include:

    • Surgery: removal of tumors or affected tissues.

    • Radiation therapy: targeting cancer cells to destroy them.

    • Chemotherapy: administering drugs to kill rapidly dividing cancer cells.

    • Hormonal therapy: aims to disrupt hormone-driven cancer cell growth.

    • Limitations of these treatments:

    • Difficulty in removing tumors depending on location.

    • Challenges in radiation and chemotherapy to selectively target only cancer cells.

    • These treatments often lead to damage in healthy tissues.

    • Ongoing research is directed towards pharmaceuticals that target specific proteins involved in cancer-related molecular pathways.